A federal judge’s decision to revoke the FDA’s approval of the abortion pill mifepristone has led some politicians to ask the Biden Administration not to enforce the ruling. Yet NARAL Pro-Choice America President Mini Timmaraju, who’s in close contact with the White House, tells “Conversations on Health Care” that’s not the right move. “I think calls for the FDA not to comply, while you know emotionally satisfying, are not actually helpful in a litigation strategy. And our goal is for the FDA and the DOJ to prevail in this case. The ruling…is riddled with serious disinformation.”
Timmaraju explains how the Supreme Court could hear the case by the end of this week and how this judge’s opinion could have an even bigger impact on the entire health care sector. Her interview with Mark Masselli and Margaret Flinter is online now.